课题基金 / 基金详情

Overcoming antibiotic resistance: rapid discovery of new antibacterial drug targets using chemical proteomics

Overcoming antibiotic resistance: rapid discovery of new antibacterial drug targets using chemical proteomics
克服抗生素耐药性:利用化学蛋白质组学快速发现新的抗菌药物靶点
批准号:
FT130100142
负责人:
A/Prof Andrew Piggott
金额:
$52.54万
依托单位:
依托单位国家:
澳大利亚
项目类别:
ARC Future Fellowships
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-04-07 至 2019-06-30

项目摘要

项目成果

A/Prof Andrew Piggott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The prevalence of multidrug-resistant bacteria in the community is a critical public health issue and there is an urgent and compelling need for new antibiotics with novel modes of action to combat these deadly superbugs. While antibiotics from nature have long been a mainstay of the pharmaceutical industry, their development as drugs can be challenging as their cellular targets and modes of action are frequently unknown. In this project, innovative chemical proteomics approaches will be used to rapidly identify and characterise the cellular targets and modes of action of both newly discovered and historic antibiotic natural products, thereby overcoming this bottleneck and accelerating the development of next-generation antibiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reverse chemical proteomics: harnessing yeast display for drug discovery
  • 批准号:
    DP180102569
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.29万
  • 财政年份:
    2018
  • 负责人:
    A/Prof Andrew Piggott
  • 依托单位:
国内基金
海外基金
水环境中新兴污染物类抗生素效应(Like-Antibiotic Effects,L-AE)作用机制研究
  • 批准号:
    21477024
  • 项目类别:
    面上项目
  • 资助金额:
    86.0万元
  • 批准年份:
    2014
  • 负责人:
    李丹
  • 依托单位: